Bonita David P bought PRLD

June 9, 2026 · Form 4 insider transaction

Bonita David P bought 38,000 shares of Prelude Therapeutics Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
38,000
Price
$0.00
Total value
N/A
RoleDirector
SecurityDirector Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 9, 2026
Filing dateJune 10, 2026
Shares owned after38,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person's provision of service to the Issuer on each vesting date.; Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP.

View the original Form 4 on SEC EDGAR